Insider trades
Chaim Lebovits, CEO of Brainstorm Cell Therapeutics BCLI, has filed 13 purchases and 0 sales on the open market. The latest trade was on 02/26.
Chaim Lebovits
President & CEO
- First filing
- 23/01/04
- Trades
- 30 trades
- Buys / sales
- 13 / 0
- 12-month net buying
- No record
- Last trade
- 02/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BCLI | Open-market buy | 24/09/30–24/10/01 | 24/10/02 | 23,836 sh2 trades | $0.48avg. | $11,357.48 | +41.7% |
BCLI | Open-market buyAmendment | 24/04/17–24/05/28 | 24/07/31 | 566,372 sh11 trades | $0.48avg. | $273,419.16 | +94.6% |